These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27824918)

  • 21. Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea.
    Vega CG; Bok M; Vlasova AN; Chattha KS; Gómez-Sebastián S; Nuñez C; Alvarado C; Lasa R; Escribano JM; Garaicoechea LL; Fernandez F; Bok K; Wigdorovitz A; Saif LJ; Parreño V
    PLoS Pathog; 2013; 9(5):e1003334. PubMed ID: 23658521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gnotobiotic piglet as a model for studies of disease pathogenesis and immunity to human rotaviruses.
    Saif LJ; Ward LA; Yuan L; Rosen BI; To TL
    Arch Virol Suppl; 1996; 12():153-61. PubMed ID: 9015112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.
    Azevedo MP; Vlasova AN; Saif LJ
    Expert Rev Vaccines; 2013 Feb; 12(2):169-81. PubMed ID: 23414408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
    Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
    Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen.
    Hoshino Y; Saif LJ; Sereno MM; Chanock RM; Kapikian AZ
    J Virol; 1988 Mar; 62(3):744-8. PubMed ID: 2828669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus.
    Yuan L; Kang SY; Ward LA; To TL; Saif LJ
    J Virol; 1998 Jan; 72(1):330-8. PubMed ID: 9420231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of killed and modified live porcine rotavirus vaccines in cesarean derived colostrum deprived pigs.
    Welter MW; Welter CJ
    Vet Microbiol; 1990 Apr; 22(2-3):179-86. PubMed ID: 2162098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of maternal and pre-existing antibodies on immunogenicity of inactivated rotavirus vaccines.
    Zhou Y; Hu X; Chen R; Wu J; Lin X; Lu C; Yin N; Tang Y; Shi P; Song Z; Zhao Y; Sun M; Li H
    Vaccine; 2022 Jun; 40(28):3843-3850. PubMed ID: 35644669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of a thermally inactivated rotavirus vaccine in mice.
    Jiang B; Wang Y; Saluzzo JF; Bargeron K; Frachette MJ; Glass RI
    Hum Vaccin; 2008; 4(2):143-7. PubMed ID: 18382129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice.
    Resch TK; Wang Y; Moon SS; Joyce J; Li S; Prausnitz M; Jiang B
    Sci Rep; 2018 Jan; 8(1):561. PubMed ID: 29330512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic pig model.
    Azevedo MS; Gonzalez AM; Yuan L; Jeong KI; Iosef C; Van Nguyen T; Lovgren-Bengtsson K; Morein B; Saif LJ
    Clin Vaccine Immunol; 2010 Mar; 17(3):420-8. PubMed ID: 20107005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs.
    Nguyen TV; Iosef C; Jeong K; Kim Y; Chang KO; Lovgren-Bengtsson K; Morein B; Azevedo MS; Lewis P; Nielsen P; Yuan L; Saif LJ
    Vaccine; 2003 Sep; 21(25-26):4059-70. PubMed ID: 12922143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model.
    Yuan L; Saif LJ
    Vet Immunol Immunopathol; 2002 Sep; 87(3-4):147-60. PubMed ID: 12072229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enumeration of isotype-specific antibody-secreting cells derived from gnotobiotic piglets inoculated with porcine rotaviruses.
    Chen WK; Campbell T; VanCott J; Saif LJ
    Vet Immunol Immunopathol; 1995 Apr; 45(3-4):265-84. PubMed ID: 7676610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
    Jiang B; Gentsch JR; Glass RI
    Vaccine; 2008 Dec; 26(52):6754-8. PubMed ID: 18951937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histo-Blood Group Antigen-Producing Bacterial Cocktail Reduces Rotavirus A, B, and C Infection and Disease in Gnotobiotic Piglets.
    Raev SA; Kick MK; Chellis M; Amimo JO; Saif LJ; Vlasova AN
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.
    Tô TL; Ward LA; Yuan L; Saif LJ
    J Gen Virol; 1998 Nov; 79 ( Pt 11)():2661-72. PubMed ID: 9820141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced rotavirus vaccine efficacy in protein malnourished human-faecal-microbiota-transplanted gnotobiotic pig model is in part attributed to the gut microbiota.
    Srivastava V; Deblais L; Huang HC; Miyazaki A; Kandasamy S; Langel SN; Paim FC; Chepngeno J; Kathayat D; Vlasova AN; Saif LJ; Rajashekara G
    Benef Microbes; 2020 Dec; 11(8):733-751. PubMed ID: 33245014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.